GETI.B

192.4

+0.58%↑

CAMX

665

-0.89%↓

VITR

138.5

+0.65%↑

ARJOB

33.5

+0.84%↑

MSON.B

7.72

-0.77%↓

GETI.B

192.4

+0.58%↑

CAMX

665

-0.89%↓

VITR

138.5

+0.65%↑

ARJOB

33.5

+0.84%↑

MSON.B

7.72

-0.77%↓

GETI.B

192.4

+0.58%↑

CAMX

665

-0.89%↓

VITR

138.5

+0.65%↑

ARJOB

33.5

+0.84%↑

MSON.B

7.72

-0.77%↓

GETI.B

192.4

+0.58%↑

CAMX

665

-0.89%↓

VITR

138.5

+0.65%↑

ARJOB

33.5

+0.84%↑

MSON.B

7.72

-0.77%↓

GETI.B

192.4

+0.58%↑

CAMX

665

-0.89%↓

VITR

138.5

+0.65%↑

ARJOB

33.5

+0.84%↑

MSON.B

7.72

-0.77%↓

Search

Attendo AB

Cerrado

69.1 0.88

Resumen

Variación precio

24h

Actual

Mínimo

68

Máximo

69.5

Métricas clave

By Trading Economics

Ingresos

-293M

88M

Ventas

-58M

4.7B

P/B

Media del Sector

18.901

40.048

BPA

0.85

Rentabilidad por dividendo

1.79

Margen de beneficio

1.879

Empleados

33,000

EBITDA

19M

880M

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

1.79%

2.45%

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

1.2B

11B

Apertura anterior

68.22

Cierre anterior

69.1

Attendo AB Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

4 ago 2025, 21:42 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone

4 ago 2025, 21:21 UTC

Ganancias
Principales Movimientos del Mercado

Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update

4 ago 2025, 20:45 UTC

Ganancias

Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb

4 ago 2025, 19:15 UTC

Principales Movimientos del Mercado

TransMedics Group Shares Rise on FDA Approval for Clinical Trial

4 ago 2025, 23:41 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

4 ago 2025, 23:41 UTC

Charlas de Mercado

Nikkei May Rise on Fed Stimulus Hopes

4 ago 2025, 23:28 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

4 ago 2025, 23:28 UTC

Charlas de Mercado

Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk

4 ago 2025, 21:30 UTC

Ganancias

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4 ago 2025, 21:21 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com

4 ago 2025, 21:18 UTC

Ganancias

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4 ago 2025, 20:25 UTC

Charlas de Mercado

India Hits Back Over Russian Oil Purchases -- Market Talk

4 ago 2025, 20:25 UTC

Ganancias

Transocean 2Q Loss $938M >RIG

4 ago 2025, 20:25 UTC

Ganancias

Transocean 2Q Loss/Shr $1.06 >RIG

4 ago 2025, 20:18 UTC

Ganancias

Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com

4 ago 2025, 20:15 UTC

Ganancias

Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX

4 ago 2025, 20:14 UTC

Ganancias

Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX

4 ago 2025, 20:14 UTC

Ganancias

Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX

4 ago 2025, 20:14 UTC

Ganancias

Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX

4 ago 2025, 20:13 UTC

Ganancias

Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX

4 ago 2025, 20:09 UTC

Ganancias

Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM

4 ago 2025, 20:06 UTC

Ganancias

Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com

4 ago 2025, 20:01 UTC

Ganancias

Vertex Pharmaceuticals 2Q Net $1.03B >VRTX

4 ago 2025, 20:01 UTC

Ganancias

Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX

4 ago 2025, 20:01 UTC

Ganancias

Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX

4 ago 2025, 20:01 UTC

Ganancias

Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX

4 ago 2025, 19:41 UTC

Charlas de Mercado

U.S. Natural Gas Futures Settle Lower -- Market Talk

4 ago 2025, 19:28 UTC

Charlas de Mercado

U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk

4 ago 2025, 19:07 UTC

Charlas de Mercado

Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk

4 ago 2025, 18:27 UTC

Charlas de Mercado

Gold Climbs on Rate Cut Speculation -- Market Talk

Comparación entre iguales

Cambio de precio

Attendo AB Esperado

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Attendo AB

Attendo AB (publ) provides health and care services in Scandinavia and Finland. The company offers nursing homes for people with dementia or physical care requirements; home care services, including care, meals, cleaning, laundry, evening and night, and home health care services for older people; homes for people of various ages with a range of disabilities or care needs; respite and companion services, as well as short term accommodation; homes and other care services for people with neuropsychiatric and psychosocial impairments; and social-worker supported foster care, crisis and emergency accommodation, HVB-homes, addiction care, and various forms of supportive housing services. Attendo AB (publ) was founded in 1985 and is headquartered in Danderyd, Sweden.